Search
Oct. 23, 2020, New York, NY — Patients with diabetic kidney disease can potentially be treated with a new investigational medication that may slow the progress of their illness without harmful side effects to their hearts, according to the results of a global clinical trial announced today.
“This is an...
Foundation and federal government work together to spread the word
September 22, 2020, New York, NY – The National Kidney Foundation (NKF) is partnering with the Centers for Disease Control and Prevention (CDC) on spreading the word that everyone, especially patients with kidney disease, should get a flu vaccine this fall.
Influenza...
~Collaboration aims to transform kidney transplantation and enhance health equity~
(September 21, 2023, New York, NY) – The National Kidney Foundation (NKF) is proud to announce its latest investment through the NKF Innovation Fund, which is aimed at fostering innovation and advancing kidney health. NKF has chosen to invest in...
Statement from Kevin Longino, CEO of the National Kidney Foundation (NKF) and a transplant recipient, on the signing of the U.S. Organ Procurement and Transplantation Network (OPTN) Act into law
(September 22, 2023 - Washington, DC) - This is a game changer!
The Securing U.S. Organ Procurement and Transplantation Network (OPTN) Act will help improve the...
Foundation Educates Public on Link between Kidney Disease, Diabetes and Heart Disease
May 19, 2022, New York, NY – Chronic diseases are the leading causes of death and disability in the United States and represent a substantial public health burden.[1] To help patients at varying levels of health literacy understand the connection between...
Collaboration Sets the Stage for an Enhanced National Registry for All Stages and Types of Kidney Disease
(November 01, 2023, New York, NY) - The National Kidney Foundation (NKF) and HHS Technology Group, LLC™ (HTG) have reached an agreement to collaborate on the KidneyCARE (Community Access to Research Equity)TM Study, the new...